Education
About Us
Working with TipRanks
Follow Us
Insmed (INSM)
:INSM
Total Valuation
Insmed has a market cap or net worth of $27.00B. The enterprise value is $17.94B.
Market Cap$27.00B
Enterprise Value$17.94B
Share Statistics
Insmed has 211,374,790 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding211,374,790
Owned by Insiders0.97%
Owned by Institutions40.48%
Financial Efficiency
Insmed’s return on equity (ROE) is -3.20 and return on invested capital (ROIC) is -50.68%.
Return on Equity (ROE)-3.20
Return on Assets (ROA)-0.45
Return on Invested Capital (ROIC)-50.68%
Return on Capital Employed (ROCE)-0.51
Revenue Per Employee286.16K
Profits Per Employee-718.94K
Employee Count1,271
Asset Turnover0.18
Inventory Turnover0.87
Valuation Ratios
The current PE Ratio of Insmed is ―. Insmed’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value39.69
Price to FCF―
Price to Operating Cash Flow-27.54
PEG Ratio―
Income Statement
In the last 12 months, Insmed had revenue of 363.71M and earned -913.77M in profits. Earnings per share was -5.57.
Revenue363.71M
Gross Profit277.96M
Operating Income-878.25M
Pretax Income-910.07M
Net Income-913.77M
EBITDA-814.14M
Earnings Per Share (EPS)-5.57
Cash Flow
In the last 12 months, operating cash flow was -844.55M and capital expenditures -24.02M, giving a free cash flow of -868.57M billion.
Operating Cash Flow-844.55M
Free Cash Flow-868.57M
Free Cash Flow per Share-4.11
Dividends & Yields
Insmed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change67.65%
50-Day Moving Average101.49
200-Day Moving Average80.02
Relative Strength Index (RSI)84.98
Average Volume (3m)2.71M
Important Dates
Insmed upcoming earnings date is Oct 23, 2025, TBA (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateOct 23, 2025
Ex-Dividend Date―
Financial Position
Insmed as a current ratio of 5.45, with Debt / Equity ratio of 59.48%
Current Ratio5.45
Quick Ratio5.12
Debt to Market Cap0.11
Net Debt to EBITDA-0.93
Interest Coverage Ratio-10.34
Taxes
In the past 12 months, Insmed has paid 3.71M in taxes.
Income Tax3.71M
Effective Tax Rate>-0.01
Enterprise Valuation
Insmed EV to EBITDA ratio is -14.84, with an EV/FCF ratio of -17.12.
EV to Sales33.21
EV to EBITDA-14.84
EV to Free Cash Flow-17.12
EV to Operating Cash Flow-17.66
Balance Sheet
Insmed has $1.86B in cash and marketable securities with $743.34M in debt, giving a net cash position of -$1.11B billion.
Cash & Marketable Securities$1.86B
Total Debt$743.34M
Net Cash-$1.11B
Net Cash Per Share-$5.27
Tangible Book Value Per Share$0.55
Margins
Gross margin is 75.40%, with operating margin of -241.47%, and net profit margin of -251.24%.
Gross Margin75.40%
Operating Margin-241.47%
Pretax Margin-250.22%
Net Profit Margin-251.24%
EBITDA Margin-223.84%
EBIT Margin-228.15%
Analyst Forecast
The average price target for Insmed is $142.29, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$142.29
Price Target Upside11.38% Upside
Analyst ConsensusStrong Buy
Analyst Count18
Revenue Growth Forecast21.15%
EPS Growth Forecast-5.65%